Valuation: Fusen Pharmaceutical Company Limited

Market Cap 531M 621M 79.15M 68.94M 65.25M 59.28M 111M 7.58B 111M 777M 301M 3.85B 297M 291M 12.33B P/E 2024
-2.95x
P/E 2025 -45.1x
Enterprise Value 753M 881M 112M 97.77M 92.53M 84.07M 157M 10.75B 158M 1.1B 426M 5.46B 422M 412M 17.49B EV / Sales 2024
2.83x
EV / Sales 2025 2.76x
Free-Float
26.11%
Yield 2024 *
-
Yield 2025 -
1 week+5.00%
Current month+5.00%
1 month-22.22%
3 months-14.29%
6 months-32.80%
Current year+5.00%
1 week 0.8
Extreme 0.8
0.86
1 month 0.67
Extreme 0.67
1.06
Current year 0.67
Extreme 0.67
1.44
1 year 0.64
Extreme 0.64
1.44
3 years 0.24
Extreme 0.235
1.75
5 years 0.24
Extreme 0.235
3
10 years 0.24
Extreme 0.235
20
Manager TitleAgeSince
Director of Finance/CFO 48 2019-04-17
Investor Relations Contact 40 2013-01-17
Corporate Secretary 36 2024-09-29
Director TitleAgeSince
Director/Board Member 63 2017-04-06
Director/Board Member 64 2017-04-06
Director/Board Member 61 2017-04-06
Date Insider Type Main position Quantity % Market Cap. Importance
4/19/24 Other

Chairman

650,000 0.0867%
4/18/24 Other

Chairman

240,000 0.0320%
4/18/24 Other

Chairman

240,000 0.0320%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+5.00%-36.84%-42.07% 79.16M
+0.74%+0.34%+15.25%+62.40% 46.36B
-0.76%-1.63%+36.36%+100.18% 36.94B
+2.49%+1.55%+9.80%+75.89% 11.52B
+1.35%+0.22%-11.75%+11.40% 11.44B
0.00%+0.57%+18.78%+148.82% 9.17B
+1.43%+2.32%+29.48%+38.91% 7.27B
+0.25%+0.04%+18.29%+182.08% 7.09B
+0.40%+3.45%+39.53%-17.99% 7.06B
+1.38%-2.74%-42.62%+6.68% 4.92B
Average +0.73%-0.07%+7.63%+56.63% 14.18B
Weighted average by Cap. +0.51%-2.10%+18.41%+73.60%

Financials

2024 2025
Net sales 326M 381M 48.61M 42.34M 40.07M 36.41M 68.02M 4.66B 68.35M 477M 185M 2.37B 183M 179M 7.57B 273M 320M 40.76M 35.5M 33.6M 30.53M 57.03M 3.9B 57.31M 400M 155M 1.98B 153M 150M 6.35B
Net income -189M -221M -28.15M -24.52M -23.2M -21.08M -39.39M -2.7B -39.58M -276M -107M -1.37B -106M -103M -4.39B -11.78M -13.79M -1.76M -1.53M -1.45M -1.32M -2.46M -168M -2.47M -17.25M -6.67M -85.52M -6.6M -6.45M -274M
Net Debt 367M 430M 54.76M 47.69M 45.14M 41.01M 76.62M 5.24B 77M 538M 208M 2.67B 206M 201M 8.53B 222M 260M 33.1M 28.83M 27.29M 24.79M 46.31M 3.17B 46.54M 325M 126M 1.61B 124M 122M 5.16B
Logo Fusen Pharmaceutical Company Limited
Fusen Pharmaceutical Co Ltd is a company mainly engaged in the cultivation of Chinese herbal medicine, pharmaceutical research and development, and sales. The Company's main business is the sales of Shuanghuanglian Oral Solutions, Shuanghuanglian Injections and other pharmaceutical products. The Company is also engaged in the research, production, and sales of various proprietary Chinese medicine and western medicine products for treating cold, fever, cardiovascular diseases and anemia. The Company mainly conducts business in the domestic market.
Employees
817
Date Price Change Volume
26-09-17 HK$0.8400 0.00% 3,000
26-09-16 HK$0.8400 -1.18% 49,000
26-09-15 HK$0.8500 0.00% 0
26-09-14 HK$0.8500 +6.25% 232,000
26-09-11 HK$0.8000 0.00% 0
  1. Stock Market
  2. Stocks
  3. 1652 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!